OTCMKTS:IDXG Interpace Biosciences Q1 2026 Earnings Results & Report $6.05 0.00 (0.00%) As of 11/13/2026 12:31 PM Eastern Interpace Biosciences reported Q1 2026 earnings on May 12, 2026. The company reported EPS of $0.15, while revenue was $9.03 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ1 2026Report DateMay 12, 2026TimeAfter Market ClosesConference Call7:00 AM ET Interpace Biosciences EPS ResultsActual EPS$0.15Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate1 of last 5 quartersInterpace Biosciences Revenue ResultsActual Revenue$9.03 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Interpace Biosciences Q1 2026 Earnings FAQ Did Interpace Biosciences beat earnings estimates for Q1 2026? Interpace Biosciences (OTCMKTS:IDXG) reported earnings of $0.15 per share for Q1 2026. The report was announced on Tuesday, May 12, 2026. What was Interpace Biosciences' revenue for Q1 2026? Interpace Biosciences reported revenue of $9.03 million for Q1 2026. Interpace Biosciences Earnings HeadlinesPDI: High Yield, Persistent Risks, But I'm Staying InvestedNovember 13 at 8:31 AM | seekingalpha.comPDI Gold Outlines West African Gold Projects in Investor PresentationNovember 10, 2026 | tipranks.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.November 16 at 1:00 AM | Behind the Markets (Ad)Core Sampling Completed for İzmir Hospital Conversion ProjectNovember 10, 2026 | tipranks.comTAPDİ Oksijen Announces Nine-Month Consolidated Operating ReviewNovember 5, 2026 | tipranks.comTAPDİ Oksijen Releases September 2026 Consolidated Financial StatementsNovember 5, 2026 | tipranks.comSee More Interpace Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Interpace Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Interpace Biosciences and other key companies, straight to your email. Email Address About Interpace BiosciencesInterpace Biosciences (OTCMKTS:IDXG) is a molecular diagnostics company that develops and provides tests to help clinicians assess cancer risk and guide treatment decisions. Its services combine molecular analysis with pathology and related diagnostic expertise. The company’s tests focus on conditions including pancreatic cysts and thyroid nodules. Its offerings have included PancraGEN for pancreatic cyst assessment, as well as ThyGeNEXT and ThyraMIR for evaluating thyroid nodules. Interpace has also offered molecular testing for gastrointestinal cancers. Interpace Biosciences, formerly known as PDI, Inc., serves healthcare providers and patients primarily in the United States through its diagnostic testing services.View Interpace Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/13Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCerebras Q3 Results: How Much More Proof Does Wall Street Need?Applied Materials Beats and Raises, But Investors Stay Unconvinced3 Power and Grid Stocks That Could Keep Growing Even if AI Spending SlowsYETI Beat on Earnings, But Its Sales Tell a Different Story Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.